期刊文献+

Ⅰ_(b1)-Ⅱ_b期宫颈癌术后同步放化疗的Ⅰ期临床研究 被引量:1

Phase Ⅰ trial of postoperative concurrent radiochemotherapy for patients with Ⅰ_(b1)-Ⅱ_b cervical carcinoma
下载PDF
导出
摘要 目的:对比宫颈癌术后同步放化疗和化疗+放疗+化疗交替治疗的毒性、依从性和近期疗效,探索宫颈癌术后同步放化疗的可行性。方法:自2003年1月至2007年6月,行广泛全宫切除+盆腔淋巴结清扫的Ⅰ_(b1)-Ⅱ_b期宫颈癌,术后病理提示有肿瘤复发高危因素,拟行术后辅助治疗者,随机分成A、B两组,各30例,A组同步放化疗,B组采用化疗+放疗+化疗交替治疗,对比两组患者治疗过程中的体重下降、骨髓抑制、胃肠道反应、肝肾毒性、皮肤反应、膀胱毒性、直肠毒性等急性放化疗反应的程度和患者的依从性,观察近期疗效。结果:两组治疗过程中的骨髓抑制、胃肠道反应、肝肾毒性、皮肤反应、膀胱反应、直肠反应程度相近,重度毒性反应发生率比较,无统计学差异,均无由于毒副反应无法耐受而终止治疗者。随访期内,A组2例发生远处转移,均已死亡,B组2例发生腹主动脉旁淋巴结转移,1例死亡,1例挽救治疗中;两组肿瘤控制率相近。结论:宫颈癌术后同步放化疗并不明显加重毒副反应,治疗依从性好,近期疗效满意。宫颈癌术后同步放化疗是可行的。 Objectives:To compare the treatment toxicity, compliance, and short -term outcome of cervical carcinoma treated with postoperative concurrent radiochemotherapy and in - turn treatment with chemo - radio - chemo- therapy and to explore the feasibility of postoperative concurrent radiochemotherapy for ⅠbI-Ⅱb cervical carcinoma. Methods:From 2003 through 2007, 60 patients with FIGO stage ⅠbI-Ⅱb cervical carcinoma treated with extensive hysterectomy plus pelvic dissection who were proven with high risk pathologic factors and adjuvant radiotherapy required were enrolled in the study and randomized divided into 2 groups, equally 30 cases in each group. Group A were treated with concurrent radiochemothcrapy, while group B were treated with chemo - radio - chemotherapy. Weight lost, marrow suppress, acute toxicity of gastrointestinal, liver, kidney, skin, bladder, and rectum, as well as treatment compliance and short - term tumor control of the two groups were compared. Results: Weight lost, marrow suppress, acute toxicity of gastrointestinal, liver, kidney, skin, bladder, and rectum reactions were comparable be- tween two groups. No case dropped out due to unendurable treatment toxicity. Within follow - up period, 2 cases died of distant metastasis in group A. 2 cases in group B had para - aortic lymph node metastasis, 1 died, while the other case is receiving salvage treatment. Conclusion:Acceptable toxicity, satisfying treatment compliance and short -term tumor outcome suggest that postoperative concurrent radiochemotherapy is feasible for cervical carcinoma.
出处 《现代肿瘤医学》 CAS 2008年第8期1378-1380,共3页 Journal of Modern Oncology
关键词 宫颈癌 同步放化疗 Ⅰ期临床研究 cervical carcinoma concurrent radiochemotherapy phase I clinical study
  • 相关文献

参考文献16

  • 1林仲秋,苏琛辉.宫颈癌术后辅助放疗[J].中国实用妇科与产科杂志,2006,22(8):568-569. 被引量:10
  • 2Jain P, Hunter RD, Livsey JE, et al. Pattern of failure and long - term morbidity in patients undergoing postoperative radiotherapy for cervical cancer[J]. Int J Gynecol Cancer, 2006,16(5) :1839 - 1845.
  • 3Kodama J, Seki N, Nakamura K, et al. Prognostic factors in pathologic parametrium - positive patients with stage IB -IIB cervical cancer treated by radical surgery and adjuvant therapy[ J ]. Gynecol Oncol, 2007,105(3) :757 -761.
  • 4Green JA, Kiwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and metaanalysis[ J]. Lancet, 2001, 358(9284) :781 - 786.
  • 5楼洪坤.关注宫颈癌的同步放化疗[J].肿瘤学杂志,2006,12(5):360-362. 被引量:2
  • 6Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC) [ J ]. Int J Radiation Oncology Biol Phys, 1995,31 (5) : 1341 - 1346.
  • 7Kodaira T, Fuwa N, Nakanishi T, et al. Long -term clinical outcomes of postoperative pelvic radiotherapy with or without prophylactic paraaortic irradiation for stage Ⅰ - Ⅱ cervical carcinoma with positive lymph nodes: retrospective analysis of predictive variables regarding survival and failure patterns [ J ]. Am J Clin Oncol, 2004,27 (2) : 140 - 148.
  • 8章文华,吴令英,白萍,李淑敏,张蓉,李斌,孙建衡,吴爱如.ⅠB期和ⅡA期宫颈癌患者的预后因素分析[J].中华肿瘤杂志,2004,26(8):490-492. 被引量:41
  • 9Uno T, Isobe K, Yamamoto S, et al. Postoperative radiation therapy for carcinoma of the uterine cervix [ J ]. Radiat Med, 2006,24 (2) :91 -97.
  • 10Eifel P J, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para - aortic irradiation for high - risk cervical cancer: an update of radiation therapy oncology group trial[J]. J Clin Oncol, 2004,22(5) :872-880.

二级参考文献61

  • 1Duenas-Gonzalez A, Cetina L, Mariscal I, et al. Modern management of locally advanced cervical carcinoma [J]. Cancer Treat Rev, 2003, 29(5): 389~399
  • 2Napolitano U, Imperato F, Mossa B, et al. The role of neoadjuvant chemotherapy for squamous cell cervical cancer (IB~ⅢB): a long-termrandomized trial[J]. EurJ Gynaecol Oncol, 2003, 24(1):51~59
  • 3Dowdy SC, Boardman CH, Walson TO, et al. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin,and cisplatin (MVAG) for stage Ⅱ B-Ⅳ cervical cancer[J]. Am J Obstet Gynecol, 2002, 186(6): 1167~1173
  • 4Moore DH. Treatment Of stageIB2 (bulky) cervical carcinoma [J].Cancer Treat Rev, 2003, 29(5): 401~406
  • 5Tabata T, Takeshima N, Nishida H, et al. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP)chemotherapy followed by radio therapy versus radiotherapy alone in stage Ⅲ B- Ⅳ A squamous cell carcinoma of the cervix [J]. Anticancer Res, 2003, 23(3C): 2885~2890
  • 6Lorvidhaya V, Chitapanarux I, Sangruchi S, et al. Concurrent mitomycin C, 5- fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial[J].IntJ Radiat Oncol Biol Phys, 2003, 55(5): 1226~1232
  • 7Kim JS, Kim SY, Kim KH, et al. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix [J]. Int J Radiat Oncol Biol Phys,2003, 55 (5): 1247~1253
  • 8Berclaz G, Gerber E, Beer K, et al. Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervic al cancer. 12-year survival after radiochemotherapy [J]. Int J Oncol, 2002, 20(6): 1313~1318
  • 9Vrdoljak E, Hamm W. Current state of the art of concomitant chemoradiation in cervical carcinoma [J]. Eur J Gynecol Oncol,2003, 24(6): 475~479
  • 10Cerrotta A, Gardan G, Cavina R, et al. Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose[J]. EurJ Gynecol Oncol, 2002, 23(2): 115~119

共引文献52

同被引文献20

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部